Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

27 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-02-25

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current investigation has been designed to test the feasibility of a mindfulness-based social cognition training (SocialMind) for people with a first episode of psychosis (AGES-Mind Study, NCT03309475). The intervention has been designed by professionals with both formal training and clinical experience in the field of mindfulness and third generation cognitive-behavioral therapies. Main outcomes are recruitment rate, adverse events and treatment adherence, although therapy effects and adjustment to intervention manual are also explored.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)

NCT03309475

Schizophrenia and Disorders With Psychotic Features Psychotic Episode

COMPLETED NA

Exploring the Feasibility of Social Skills Training in People With Psychosis

NCT02235649

Focus of Study

COMPLETED NA

Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders

NCT03671005

Psychotic Disorder

TERMINATED NA

Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis

NCT06870305

Clinical High Risk for Psychosis (CHR)

NOT_YET_RECRUITING NA

Mindfulness Intervention for People With Psychosis

NCT03501862

Recent-onset Psychosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Social functioning is impaired among many patients with a first episode of psychosis, who also show a lower ability to recognize, understand and benefit from social stimuli (i.e., deficits in social cognition) than their pairs. Both deficits underlie the general functional impairment found across non-affective psychotic syndromes. Since currently available pharmacological strategies have not proven themselves effective in addressing this matter, new psychotherapeutic approaches should be developed. This research team developed a mindfulness-based social cognition group training (SocialMind) designed for persons who have suffered a first episode of psychosis within five years prior to their enrollment in the study (AGES-Mind Study, NCT03309475). Although there is enough evidence to support the lack of adverse events derived for mindfulness-based interventions specifically designed for psychotic patients (Cramer et al., 2016), many clinicians express their concerns about the beneficial effects of these approaches. Therefore, and in keeping with international health organisms such as United Kingdom's National Health Service (NHS), this team have proposed a feasibility study. The main hypothesis is that the AGES-Mind study can be carried out in terms of achievement of recruitment rate, lack of adverse events and levels of treatment adherence. Secondary hypothesis states that clinicians will adhere to SocialMind manual. Finally, a positive effect of the intervention is expected, both in participants' satisfaction and in some relevant variables, such as functional outcomes, clinical global impression and social cognition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia and Disorders With Psychotic Feature Psychotic Episode

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Multi-center, open-label, prospective, non-randomized, single-group, clinical trial. The experimental arm will receive TAU (both drug and psychosocial therapy) and mindfulness-based social cognition group training (SocialMind), specifically designed for patients with first episode psychosis by the research team.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SocialMind

The experimental arm will receive treatment as usual (both psychotropic treatment and psychosocial treatment) and mindfulness-based social cognition group training (SocialMind), specifically designed for patients with first episode psychosis by the research team. There will be a first phase (intensive intervention) consisting of 8 weekly sessions and a second phase (follow-up sessions) consisting of 4 fortnightly sessions and 5 monthly sessions.

Group Type EXPERIMENTAL

SocialMind

Intervention Type BEHAVIORAL

SocialMind is a mindfulness-based intervention including elements such as radical acceptance, decentering or meditation-techniques. It is designed to target social cognition, defined as the ability to recognize, understand and benefit from social stimuli.

Psychosocial treatment

Intervention Type BEHAVIORAL

Treatment as usual delivered by patient's practitioner

Psychotropic treatment

Intervention Type DRUG

Treatment as usual delivered by patient's practitioner

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SocialMind

SocialMind is a mindfulness-based intervention including elements such as radical acceptance, decentering or meditation-techniques. It is designed to target social cognition, defined as the ability to recognize, understand and benefit from social stimuli.

Intervention Type BEHAVIORAL

Psychosocial treatment

Treatment as usual delivered by patient's practitioner

Intervention Type BEHAVIORAL

Psychotropic treatment

Treatment as usual delivered by patient's practitioner

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Mindfulness-based social cognition training Mindfulness-based social cognition group training MB-SCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-60 years old
* Diagnosis of psychotic disorder according to DSM-5 and history of more than five years of psychotic symptoms
* CGI-SCH equal or lower than four points ("moderately ill")
* Informed consent given

Exclusion Criteria

* Intellectual disability plus impaired global functioning prior to disorder onset
* Generalized development disorder
* Substance related disorders (except for nicotine) according to DSM-5

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No